Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma

Drug resistance to anti-cancer agents is a major concern regarding the successful treatment of malignant tumors. Recent studies have suggested that acquired resistance to anti-epidermal growth factor receptor (EGFR) therapies such as cetuximab are in part caused by genetic alterations in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Uzawa, Katsuhiro, Amelio, Antonio L., Kasamatsu, Atsushi, Saito, Tomoaki, Kita, Akihiro, Fukamachi, Megumi, Sawai, Yuki, Toeda, Yuriko, Eizuka, Keitaro, Hayashi, Fumihiko, Kato-Kase, Ikuko, Sunohara, Masataka, Iyoda, Manabu, Koike, Kazuyuki, Nakashima, Dai, Ogawara, Katsunori, Endo-Sakamoto, Yosuke, Shiiba, Masashi, Takiguchi, Yuichi, Yamauchi, Mitsuo, Tanzawa, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704133/
https://www.ncbi.nlm.nih.gov/pubmed/31434965
http://dx.doi.org/10.1038/s41598-019-48717-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704133/
https://www.ncbi.nlm.nih.gov/pubmed/31434965
http://dx.doi.org/10.1038/s41598-019-48717-w

Ejemplares similares